ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: The Harlem-Basset Study

Journal of Lipid Research

Volumn 48, Issue 3, 2007, Pages 693-698

  Anuurad, Erdembileg ^a   Lu, Guijing ^a   Rubin, Jill ^b   Pearson, Thomas A ^c   Berglund, Lars ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

Apolipoprotein a ; Apolipoprotein E; Ethnicity; Genetics; Lipoprotein a ; Polymorphisms

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN E;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AFRICAN AMERICANS; ALLELES; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; APOPROTEIN(A); CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33947113858     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600431-JLR200     Document Type: Article

References (47)

1. Utermann, G. 1989. The mysteries of lipoprotein(a). Science. 246: 904-910.
2. Stein, J. H., and R. S. Rosenson. 1997. Lipoprotein Lp(a) excess and coronary heart disease. Arch. Intern. Med. 157: 1170-1176.
3. Danesh, J., R. Collins, and R. Peto. 2000. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation. 102: 1082-1085.
4. Boerwinkle, E., C. C. Leffert, J. Lin, C. Lackner, G. Chiesa, and H. H. Hobbs. 1992. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90: 52-60.
5. Gaubatz, J. W., C. Heideman, A. M. Gotto, Jr., J. D. Morrisett, and G. H. Dahlen. 1983. Human plasma lipoprotein [a]. Structural properties. J. Biol. Chem. 258: 4582-4589.
6. Scanu, A. M., and C. Edelstein. 1997. Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations. J. Lipid Res. 38: 2193-2206.
7. McLean, J. W., J. E. Tomlinson, W. J. Kuang, D. L. Eaton, E. Y. Chen, G. M. Fless, A. M. Scanu, and R. M. Lawn. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 330: 132-137.
8. Kraft, H. G., A. Lingenhel, R. W. Pang, R. Delport, M. Trommsdorff, H. Vermaak, E. D. Janus, and G. Utermann. 1996. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur. J. Hum. Genet. 4: 74-87.
9. Gaw, A., E. Boerwinkle, J. C.Cohen, and H.H. Hobbs. 1994. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J. Clin. Invest. 93: 2526-2534.
10. Guyton, J. R., G. H. Dahlen, W. Patsch, J. A. Kautz, and A. M. Gotto, Jr. 1985. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis. 5: 265-272.
11. Parra, H. J., I. Luyeye, C. Bouramoue, C. Demarquilly, and J. C. Fruchart. 1987. Black-white differences in serum Lp(a) lipoprotein levels. Clin. Chim. Acta. 168: 27-31.
12. Gaubatz, J. W., K. I. Ghanem, J. Guevara, Jr., M. L. Nava, W. Patsch, and J. D. Morrisett. 1990. Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein [a]. J. Lipid Res. 31: 603-613.
13. Sandholzer, C., D. M. Hallman, N. Saha, G. Sigurdsson, C. Lackner, A. Csaszar, E. Boerwinkle, and G. Utermann. 1991. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum. Genet. 86: 607-614.
14. Marcovina, S. M., J. J. Albers, D. R. Jacobs, Jr., L. L. Perkins, C. E. Lewis, B. V. Howard, and P. Savage. 1993. Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. Arterioscler. Thromb. 13: 1037-1045.
15. Berglund, L., and R. Ramakrishnan. 2004. Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler. Thromb. Vasc. Biol. 24: 2219-2226.
16. Marcovina, S. M., J. J. Albers, E. Wijsman, Z. Zhang, N. H. Chapman, and H. Kennedy. 1996. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J. Lipid Res. 37: 2569-2585.
17. Rubin, J., H. J. Kim, T. A. Pearson, S. Holleran, R. Ramakrishnan, and L. Berglund. 2006. Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo [a]. J. Lipid Res. 47: 982-989.
18. Geethanjali, F. S., K. Luthra, A. Lingenhel, A. S. Kanagasaba-Pathy, J. Jacob, L. M. Srivastava, S. Vasisht, H. G. Kraft, and G. Utermann. 2003. Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease. Atherosclerosis. 169: 121-130.
19. Ogorelkova, M., H. G. Kraft, C. Ehnholm, and G. Utermann. 2001. Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum. Mol. Genet. 10: 815-824.
20. Chretien, J. P., J. Coresh, Y. Berthier-Schaad, W. H. Kao, N. Fink, M. J. Klag, S. M. Marcovina, F. Giaculli, and M. W. Smith. 2006. Three single-nucleotide polymorphisms in LPA account for the majority of lipoprotein(a) level elevation in African Americans compared to European Americans. J. Med. Genet. 43: 917-923.
21. Mahley,R.W., andS.C.Rall, Jr. 2000.Apolipoprotein E: farmore than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1: 507-537.
22. Moore, R. J., R. M. Chamberlain, and F. R. Khuri. 2004. Apolipoprotein E and the risk of breast cancer in African-American and non-Hispanic white women. A review. Oncology. 66: 79-93.
23. de Knijff, P., and C. M. van Duijn. 1998. Role of APOE in dementia: a critical reappraisal. Haemostasis. 28: 195-201.
24. Heng, C. K., N. Saha, and J. S. Tay. 1995. Lack of association of apolipoprotein E polymorphism with plasma Lp(a) levels in the Chinese. Clin. Genet. 48: 113-119.
25. Sandkamp, M., H. Funke, H. Schulte, E. Kohler, and G. Assmann. 1990. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin. Chem. 36: 20-23.
26. Lehtimaki, T., T. Moilanen, J. Viikari, H. K. Akerblom, C. Ehnholm, T. Ronnemaa, J. Marniemi, G. Dahlen, and T. Nikkari. 1990. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J. Lipid Res. 31: 487-495.
27. Bailleul, S., R. Couderc, C. Rossignol, J. Fermanian, F. Boutouchent, M. A. Farnier, and J. Etienne. 1995. Lipoprotein(a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis. Clin. Chem. 41: 241-245.
28. Muros, M., and C. Rodriguez-Ferrer. 1996. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis. 121: 13-21.
29. Muls, E., K. Kempen, G. Vansant, C. Cobbaert, and W. Saris. 1993. The effects of weight loss and apolipoprotein E polymorphism on serum lipids, apolipoproteins A-I and B, and lipoprotein(a). Int. J. Obes. Relat. Metab. Disord. 17: 711-716.
30. Schaefer, E. J., S. Lamon-Fava, S. Johnson, J. M. Ordovas, M. M. Schaefer, W. P. Castelli, and P. W. Wilson. 1994. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler. Thromb. 14: 1105-1113.
31. de Knijff, P., A. Kaptein, D. Boomsma, H. M. Princen, R. R. Frants, and L. M. Havekes. 1991. Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a). Atherosclerosis. 90: 169-174.
32. Klausen, I. C., L. U. Gerdes, P. S. Hansen, L. Lemming, C. Gerdes, and O. Faergeman. 1996. Effects of apoE gene polymorphism on Lp(a) concentrations depend on the size of apo(a): a study of 466 white men. J. Mol. Med. 74: 685-690.
33. Routi, T., T. Ronnemaa, P. Salo, R. Seppanen, J. Marniemi, J. Viikari, C. Ehnholm, and O. Simell. 1996. Effects of prospective, randomized cholesterol-lowering dietary intervention and apolipoprotein E phenotype on serum lipoprotein(a) concentrations of infants aged 7-24 mo. Am. J. Clin. Nutr. 63: 386-391.
34. Horita, K., M. Eto, M. Saito, H. Nakata, Y. Iwashima, H. Ito, M. Takahashi, A. Kondo, A. Morikawa, and I. Makino. 1993. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels. Artery. 20: 324-336.
35. Frikke-Schmidt, R., B. G. Nordestgaard, B. Agerholm-Larsen, P. Schnohr, and A. Tybjaerg-Hansen. 2000. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J. Lipid Res. 41: 1812-1822.
36. Lindahl, G., F. Mailly, S. Humphries, and M. Seed. 1994. Apolipoprotein E phenotype and lipoprotein(a) in familial hyper-cholesterolaemia: implication for lipoprotein(a) metabolism. Clin. Investig. 72: 631-638.
37. Paultre, F., T. A. Pearson, H. F. Weil, C. H. Tuck, M. Myerson, J. Rubin, C. K. Francis, H. F. Marx, E. F. Philbin, R. G. Reed, et al. 2000. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler. Thromb. Vasc. Biol. 20: 2619-2624.
38. Anuurad, E., J. Rubin, G. Lu, T. A. Pearson, S. Holleran, R. Ramakrishnan, and L. Berglund. 2006. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol. J. Lipid Res. 47: 2475-2481.
39. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
40. Lackner, C., J. C. Cohen, and H. H. Hobbs. 1993. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum. Mol. Genet. 2: 933-940.
41. Rubin, J., F. Paultre, C. H. Tuck, S. Holleran, R. G. Reed, T. A. Pearson, C. M. Thomas, R. Ramakrishnan, and L. Berglund. 2002. Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians. J. Lipid Res. 43: 234-244.
42. Kamboh, M. I., R. E. Ferrell, and B. A. Kottke. 1991. Expressed hypervariable polymorphism of apolipoprotein (a). Am. J. Hum. Genet. 49: 1063-1074.
43. Marcovina, S. M., H. H. Hobbs, and J. J. Albers. 1996. Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin. Chem. 42: 436-439.
44. Hixson, J. E., and D. T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
45. Marz, W., A. Beckmann, H. Scharnagl, R. Siekmeier, U. Mondorf, I. Held, W. Schneider, K. T. Preissner, L. K. Curtiss, W. Gross, et al. 1993. Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. FEBS Lett. 325: 271-275.
46. Schwiegelshohn, B., J. F. Presley, M. Gorecki, T. Vogel, Y. A. Carpentier, F. R. Maxfield, and R. J. Deckelbaum. 1995. Effects of apoprotein E on intracellular metabolism of model triglyceriderich particles are distinct from effects on cell particle uptake. J. Biol. Chem. 270: 1761-1769.
47. Mensenkamp, A. R., M. C. Jong, H. van Goor, M. J. van Luyn, V. Bloks, R. Havinga, P. J. Voshol, M. H. Hofker, K. W. van Dijk, L. M. Havekes, et al. 1999. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. J. Biol. Chem. 274: 35711-35718.